Readmissions and the quality of care in patients hospitalized with heart failure

Details

Ressource 1Download: serval:BIB_1EE144435FAB.P001 (133.75 [Ko])
State: Public
Version: author
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
Serval ID
serval:BIB_1EE144435FAB
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Readmissions and the quality of care in patients hospitalized with heart failure
Journal
International Journal for Quality in Health Care
Author(s)
Luthi Jean-Christophe, Lund Mary Jo, Sampietro-Colom Laura, Kleinbaum David G., Ballard David J. C., McClellan William M.
ISSN
1353-4505
Publication state
Published
Issued date
2003
Volume
15
Number
5
Pages
413-421
Notes
Réf. IUMSP: R 03/107 Mention de responsabiblité : / Luthi JC, Lund MJ, Sampietro-Colom L, Kleinbaum DG, Ballard DJ, McClellan WM SAPHIRID:44922 --- Old url value: http://intqhc.oupjournals.org/cgi/content/full/15/5/413
Abstract
[Abstract] OBJECTIVES: Clinical practice guidelines based on the results of randomized clinical trials recommend that patients with heart failure due to left ventricular systolic dysfunction (LVSD) be treated with angiotensin-converting enzyme inhibitors (ACEI) at doses shown to reduce mortality and readmission. This study examined the relationship between ACEI use at discharge and readmission among patients with heart failure due to LVSD. METHODS AND RESULTS: Data were abstracted from the medical records of 2943 randomly selected patients hospitalized for heart failure in 50 hospitals. The outcome of interest was the number of readmissions occurring up to 21 months after discharge. Six-hundred and eleven patients were eligible for analysis. Compared with patients discharged at a recommended ACEI dose, patients not prescribed an ACEI at discharge had an adjusted rate ratio of readmission (RR) of 1.74 [95% confidence interval (CI) 1.22-2.48], while patients prescribed an ACEI at less than a recommended dose had an RR of 1.24 (95% CI 0.91-1.69) (P = 0.005 for the trend). CONCLUSION: Our results show that ACEI use at discharge in patients with LVSD is associated with decreased rate of readmission. These findings suggest that compliance with the ACEI prescribing recommendations listed in clinical practice guidelines for patients with heart failure due to LVSD confers benefit. [Authors]
Keywords
Angiotensin-Converting Enzyme Inhibitors , Heart Failure, Congestive , Outcome and Process Assessment (Health Care) , Patient Readmission , Quality Indicators, Health Care , Ventricular Dysfunction, Left
Pubmed
Web of science
Open Access
Yes
Create date
06/03/2008 16:31
Last modification date
25/09/2019 7:08
Usage data